Delivery Order SPE2DB22D2009-SPE2DB25FL8JT

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,599.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a medical product, with a completion date of March 5, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,005.42, is a delivery order for the supply of PIMECROLIMUS 1% CREAM 60GM. The contract has a firm fixed price pricing type and an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,065.03, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of PIMECROLIMUS 1% CREAM 60GM, a topical medication. The contract has a completion date of June 4, 2024 and is a firm fixed-price arrangement. There is no set-aside designation mentioned in the information provided. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,835.77 Delivery Order contract is for the supply of Pimecrolimus 1% Cream 30GM, a specialty pharmaceutical product, to support military healthcare programs. The contract has a completion date of January 29, 2025 and utilizes a Firm Fixed Price pricing type. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.76 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a prescription medication, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,200.38, is for the delivery of PIMECROLIMUS 1% CREAM 100GM. The contract has an ultimate completion date of September 29, 2023 and is a firm-fixed price delivery order. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% Cream 30GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,431.28, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999, that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.96, is for the delivery of Pimecrolimus 1% Cream 100GM, a pharmaceutical product, and was awarded on December 21, 2023 with a completion date of December 22, 2023. The contract is a Delivery Order under a Firm Fixed Price contract type. This award is part of a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,849.89 firm fixed price delivery order is for the supply of PIMECROLIMUS CREAM, a pharmaceutical product. The contract has a completion date of February 23, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This federal contract award, valued at $1,022.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream, a topical medication, with a final completion date of August 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8JT
    Delivery Order

This federal contract award, valued at $1,469.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, and has an ultimate completion date of March 20, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/18/25, 11:12 AM